| Product Code: ETC9949139 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Molecular Diagnostics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Molecular Diagnostics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Molecular Diagnostics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume Share, By Product & Services, 2021 & 2031F |
3.6 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.8 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Kingdom (UK) Molecular Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases and chronic illnesses in the UK leading to higher demand for molecular diagnostics. |
4.2.2 Technological advancements in molecular diagnostics improving accuracy and efficiency of testing. |
4.2.3 Growing awareness among healthcare professionals and patients about the benefits of molecular diagnostics. |
4.3 Market Restraints |
4.3.1 High costs associated with molecular diagnostics tests may limit adoption, especially in smaller healthcare facilities. |
4.3.2 Regulatory challenges and stringent approval processes for new molecular diagnostic tests. |
4.3.3 Limited reimbursement options for molecular diagnostic tests in the UK healthcare system. |
5 United Kingdom (UK) Molecular Diagnostics Market Trends |
6 United Kingdom (UK) Molecular Diagnostics Market, By Types |
6.1 United Kingdom (UK) Molecular Diagnostics Market, By Product & Services |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By Product & Services, 2021- 2031F |
6.1.3 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By Kits, 2021- 2031F |
6.1.4 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By Software, 2021- 2031F |
6.2 United Kingdom (UK) Molecular Diagnostics Market, By Test Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By Lab, 2021- 2031F |
6.2.3 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By PoC, 2021- 2031F |
6.3 United Kingdom (UK) Molecular Diagnostics Market, By Sample |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By Blood, 2021- 2031F |
6.3.3 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By Urine, 2021- 2031F |
6.4 United Kingdom (UK) Molecular Diagnostics Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.4.3 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By NGS, 2021- 2031F |
6.4.4 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By ISH, 2021- 2031F |
6.4.5 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By INAAT, 2021- 2031F |
6.5 United Kingdom (UK) Molecular Diagnostics Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By Infectious, 2021- 2031F |
6.5.3 United Kingdom (UK) Molecular Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
7 United Kingdom (UK) Molecular Diagnostics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Molecular Diagnostics Market Export to Major Countries |
7.2 United Kingdom (UK) Molecular Diagnostics Market Imports from Major Countries |
8 United Kingdom (UK) Molecular Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostics technologies in UK healthcare facilities. |
8.2 Rate of incorporation of new molecular diagnostic tests in clinical practice. |
8.3 Percentage of healthcare professionals trained in molecular diagnostics techniques. |
8.4 Patient satisfaction and confidence levels in molecular diagnostic test results. |
8.5 Number of collaborations between diagnostic companies and healthcare providers for molecular diagnostics. |
9 United Kingdom (UK) Molecular Diagnostics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Molecular Diagnostics Market Opportunity Assessment, By Product & Services, 2021 & 2031F |
9.2 United Kingdom (UK) Molecular Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.3 United Kingdom (UK) Molecular Diagnostics Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.4 United Kingdom (UK) Molecular Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 United Kingdom (UK) Molecular Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Kingdom (UK) Molecular Diagnostics Market - Competitive Landscape |
10.1 United Kingdom (UK) Molecular Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Molecular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here